boston, February 20, 2024 /CNW/ — Ardigen, the world’s leading AI Contract Research Organization (AI CRO) at the forefront of AI transformation in the biotech and pharmaceutical sectors, is pleased to announce the following appointments: Livia Legg As Chief Commercial Officer. Mr. Revere will also join the company’s Board of Directors, bringing extensive leadership experience in business development and commercial operations, and will significantly strengthen Aldigen’s sales efforts and contribute to the company’s ambitious growth goals.
With an impressive track record of building large-scale ventures, Revere’s leadership and expertise will aid Ardigen’s strategic efforts to grow its business 3-5x and expand its market presence. Her appointment underscores Aldigen’s commitment to strengthening its management team and reinforcing its mission to increase the probability of success in the drug development process.
”Livia Legg “Her extensive industry experience and remarkable success in business development and commercial operations make her an invaluable addition to Ardigen’s management team.” Janusz Homa, CEO of Aldigen. “Her insight and strategic vision will be critical in the coming years as we aim for ambitious growth and expand our impact in the biotech and pharmaceutical sectors. ”
“I am excited to join Ardigen, a purpose-driven company focused on people, culture and values,” he said. Livia Legg. “Ardigen is a pioneer in the AI industry, leveraging our innovative platform, scientific insights, and seamless AI integration for pharmaceutical and biotech companies.As we accelerate Ardigen’s strategic growth plans, we continues to deliver incredible value and transformative results to clients around the world.”
about Livia Legg:
Livia Legg Revere has had a distinguished career in global business development, sales and marketing leadership, most recently serving as Chief Commercial Officer of Shanghai ChemPartner Co., Ltd. and General Manager of ChemPartner Co., Ltd. US and EU since 2015. . Revere’s career also includes vice president, executive director, from 2002 until 2015 he served as global business development officer at QPS, LLC, and from 1997 he served as vice president, executive director at MDS Pharma Services and Merck Pharmacy. Tikal He served in strategic roles at the Company.
Livia holds a Bachelor of Science (BS) in Nutritional Science and a Master of Science (MS) in Molecular, Cellular, and Biomedical Sciences. University of New Hampshire.
About Ardigen:
Ardigen, the world’s leading AI CRO, is playing a key role in the AI transformation of biotech and pharma. Their purpose is to increase the probability of success in the drug development process. They leverage advanced proprietary AI platforms and deep expertise to transform vast amounts of data into critical, actionable scientific insights. By leveraging this expertise, we also strengthen the infrastructure that allows our clients to seamlessly integrate and leverage these capabilities within their organizations.
Learn more about. ardigen.com
contact:
barbara wilova,PhD
hello@ardigen.com
+1 628 200 09 14
Photo – https://mma.prnewswire.com/media/2342636/Ardigen_New_CCO.jpg
Logo – https://mma.prnewswire.com/media/2340587/Ardigen_Logo.jpg
View original content to download multimedia: https://www.prnewswire.com/news-releases/ardigen-appoints-new-cco-to-accelerate-growth-plans-and-become- the-top-ai-cro-worldwide -302066002.html
Source Ardigen
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/20/c9849.html
